X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with JUBILANT LIFE SCIENCES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs JUBILANT LIFE SCIENCES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE JUBILANT LIFE SCIENCES TTK HEALTHCARE/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x 23.1 17.1 134.5% View Chart
P/BV x 7.8 4.5 172.0% View Chart
Dividend Yield % 0.4 0.4 92.9%  

Financials

 TTK HEALTHCARE   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
JUBILANT LIFE SCIENCES
Mar-14
TTK HEALTHCARE/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs663187 355.1%   
Low Rs39965 612.9%   
Sales per share (Unadj.) Rs535.6364.3 147.0%  
Earnings per share (Unadj.) Rs15.96.8 232.9%  
Cash flow per share (Unadj.) Rs20.024.5 81.7%  
Dividends per share (Unadj.) Rs4.003.00 133.3%  
Dividend yield (eoy) %0.82.4 31.6%  
Book value per share (Unadj.) Rs137.6164.9 83.5%  
Shares outstanding (eoy) m7.77159.28 4.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.00.3 286.9%   
Avg P/E ratio x33.318.4 181.1%  
P/CF ratio (eoy) x26.55.1 516.0%  
Price / Book Value ratio x3.90.8 505.4%  
Dividend payout %25.143.8 57.2%   
Avg Mkt Cap Rs m4,12720,061 20.6%   
No. of employees `0001.76.2 27.6%   
Total wages/salary Rs m60711,052 5.5%   
Avg. sales/employee Rs Th2,436.79,383.0 26.0%   
Avg. wages/employee Rs Th355.21,786.9 19.9%   
Avg. net profit/employee Rs Th72.5176.3 41.1%   
INCOME DATA
Net Sales Rs m4,16258,034 7.2%  
Other income Rs m61191 32.1%   
Total revenues Rs m4,22358,224 7.3%   
Gross profit Rs m1975,786 3.4%  
Depreciation Rs m322,812 1.1%   
Interest Rs m303,237 0.9%   
Profit before tax Rs m197-72 -272.8%   
Minority Interest Rs m0-286 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m02,145 0.0%   
Tax Rs m73696 10.5%   
Profit after tax Rs m1241,090 11.4%  
Gross profit margin %4.710.0 47.5%  
Effective tax rate %37.0-965.9 -3.8%   
Net profit margin %3.01.9 158.4%  
BALANCE SHEET DATA
Current assets Rs m1,62929,280 5.6%   
Current liabilities Rs m1,05838,912 2.7%   
Net working cap to sales %13.7-16.6 -82.7%  
Current ratio x1.50.8 204.6%  
Inventory Days Days3084 35.3%  
Debtors Days Days3451 66.3%  
Net fixed assets Rs m55655,712 1.0%   
Share capital Rs m78155 50.3%   
"Free" reserves Rs m87820,968 4.2%   
Net worth Rs m1,06926,265 4.1%   
Long term debt Rs m15917,169 0.9%   
Total assets Rs m2,39988,606 2.7%  
Interest coverage x7.61.0 775.1%   
Debt to equity ratio x0.10.7 22.7%  
Sales to assets ratio x1.70.7 264.8%   
Return on assets %6.44.9 131.2%  
Return on equity %11.64.2 279.1%  
Return on capital %18.511.6 159.5%  
Exports to sales %0.837.8 2.1%   
Imports to sales %1.416.5 8.5%   
Exports (fob) Rs m3321,933 0.2%   
Imports (cif) Rs m589,567 0.6%   
Fx inflow Rs m3322,004 0.1%   
Fx outflow Rs m6311,749 0.5%   
Net fx Rs m-3010,255 -0.3%   
CASH FLOW
From Operations Rs m1278,026 1.6%  
From Investments Rs m-146-1,744 8.4%  
From Financial Activity Rs m22-4,447 -0.5%  
Net Cashflow Rs m31,834 0.1%  

Share Holding

Indian Promoters % 65.4 45.6 143.4%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 3.7 8.7 42.5%  
FIIs % 5.2 21.2 24.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 21.1 122.3%  
Shareholders   12,723 23,815 53.4%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   SANOFI INDIA  ABBOTT INDIA  FRESENIUS KABI ONCO.  WYETH LTD  GSK PHARMA  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 170 Points Lower, Realty and FMCG Stocks Witness Selling(Closing)

After opening the day on a positive note, share markets in India witnessed volatile trading activity and ended in red.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY19); Net Profit Up 39.4% (Quarterly Result Update)

Jul 31, 2018 | Updated on Jul 31, 2018

For the quarter ended June 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 39.4% YoY). Sales on the other hand came in at Rs 21 bn (up 30.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

In a Crisis, if Petrol Prices Hit Rs 100, This Stock Could Be a Good Buy(The 5 Minute Wrapup)

Sep 6, 2018

The rise in the crude oil price is a major reason for the fall in the market. If crude oil prices keep on rising, what will happen to stocks?

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

Hurricanes Threaten Oil Spike, but the Saudis are Selling...(Vivek Kaul's Diary)

Sep 6, 2018

Oil prices are rising and could go even more higher amid rising tensions in Middle East.

Should You Be Worried About the Rising Dollar?(Chart Of The Day)

Sep 7, 2018

While the rupee has deprecated by about 5% annually since 1990 against the dollar, the BSE Sensex has returned 14% annually in the same period.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Sep 19, 2018 03:37 PM

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS